Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12564567 | Antiviral therapeutic compounds and compositions for use in treatment of coronavirus and influenza virus | 🖼🧊📄§ | 2026-03-03 | 2043-11-27 | 0 | 31 |
| 12564586 | Kappa opiod receptor antagonists for treating pain-related sleep disorders | 🖼🧊📄§ | 2026-03-03 | 2041-04-09 | 0 | 31 |
| 12564645 | Methods for treatment of methylmalonic acidemia | 🖼🧊📄§ | 2026-03-03 | 2039-09-13 | 0 | 31 |
| 12565476 | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors | 🖼🧊📄§ | 2026-03-03 | 2043-03-21 | 0 | 31 |
| 12564646 | Treatment of age-related cognitive decline using genetically modified viral vectors | 🖼🧊📄§ | 2026-03-03 | 2042-06-15 | 0 | 31 |
| 12564638 | EGFR protein degradant and anti-tumor application thereof | 🖼🧊📄§ | 2026-03-03 | 2040-08-05 | 0 | 31 |
| 12564602 | Contact lens treating solution | 🖼🧊📄§ | 2026-03-03 | 2042-03-10 | 0 | 31 |
| 12564625 | Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Δ5nsP3 | 🖼🧊📄§ | 2026-03-03 | 2044-05-06 | 0 | 31 |
| 12565499 | Compounds and methods | 🖼🧊📄§ | 2026-03-03 | 2044-03-11 | 0 | 31 |
| 12565480 | Thiophene derivatives as xanthine oxidase inhibitors and application thereof | 🖼🧊📄§ | 2026-03-03 | 2040-10-30 | 0 | 31 |
| 12564597 | Ibogaine analogs as therapeutics for neurological and psychiatric disorders | 🖼🧊📄§ | 2026-03-03 | 2041-03-04 | 0 | 31 |
| 12564643 | Polymeric nanovaccines and uses thereof | 🖼🧊📄§ | 2026-03-03 | 2039-12-27 | 0 | 31 |
| 12565530 | Combination therapy with targeted 4-1BB (CD137) agonists/anti-FAP binding domain and anti-CEA/anti-CD3 bispecific antibody | 🖼🧊📄§ | 2026-03-03 | 2043-02-09 | 0 | 31 |
| 12564590 | Combinations of menin inhibitors and CYP3A4 inhibitors and methods of use thereof | 🖼🧊📄§ | 2026-03-03 | 2041-04-07 | 0 | 31 |
| 12564616 | Composition for respiratory diseases | 🖼🧊📄§ | 2026-03-03 | 2044-04-19 | 0 | 31 |
| 12564629 | Vaccine to protect against mycoplasma hyopneumoniae | 🖼🧊📄§ | 2026-03-03 | 2041-04-19 | 0 | 31 |
| 12564606 | Pharmaceutical composition for treating wounds | 🖼🧊📄§ | 2026-03-03 | 2039-11-21 | 0 | 31 |
| 12564607 | Cell population comprising mesenchymal cells, pharmaceutical composition comprising the same, and method for producing the same | 🖼🧊📄§ | 2026-03-03 | 2040-06-12 | 0 | 31 |
| 12559473 | Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs | 🖼🧊📄§ | 2026-02-24 | 2044-04-30 | 0 | 31 |
| 12558399 | Isocyclosporin A for topical treatment of ocular diseases | 🖼🧊📄§ | 2026-02-24 | 2042-12-22 | 0 | 31 |
| 12558430 | Dual amylin and calcitonin receptor agonists and uses thereof | 🖼🧊📄§ | 2026-02-24 | 2042-10-28 | 0 | 31 |
| 12559449 | Aromatic ring or heteroaromatic ring derivatives, preparation method therefor and use thereof | 🖼🧊📄§ | 2026-02-24 | 2040-04-01 | 0 | 31 |
| 12558402 | Jellyfish collagen use | 🖼🧊📄§ | 2026-02-24 | 2041-06-15 | 0 | 31 |
| 12558357 | Tetrahydroquinazoline derivatives as selective cytotoxic agents | 🖼🧊📄§ | 2026-02-24 | 2041-08-25 | 0 | 31 |
| 12559503 | Anthelmintic aza-benzothiophene and aza-benzofuran compounds | 🖼🧊📄§ | 2026-02-24 | 2043-01-06 | 0 | 31 |
| 12559487 | Crosslinked optically active secondary amine derivative | 🖼🧊📄§ | 2026-02-24 | 2040-09-25 | 0 | 31 |
| 12559481 | Quinoline derivatives | 🖼🧊📄§ | 2026-02-24 | 2042-12-09 | 0 | 31 |
| 12558325 | Methods for improving neurological diseases and disorders | 🖼🧊📄§ | 2026-02-24 | 2043-02-09 | 0 | 31 |
| 12558407 | Compositions for treatment of diffuse intrinsic pontine glioma | 🖼🧊📄§ | 2026-02-24 | 2040-05-01 | 0 | 31 |
| 12559474 | Triazine derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the same | 🖼🧊📄§ | 2026-02-24 | 2042-02-17 | 0 | 31 |
| 12558405 | Pharmaceutical composition using endogenous cells for preventing or treating musculoskeletal disorders | 🖼🧊📄§ | 2026-02-24 | 2039-10-22 | 0 | 31 |
| 12559538 | PD-1 polypeptide variants | 🖼🧊📄§ | 2026-02-24 | 2041-09-08 | 0 | 31 |
| 12558351 | Compositions and methods for enhancing cancer immune checkpoint therapy | 🖼🧊📄§ | 2026-02-24 | 2040-03-20 | 0 | 31 |
| 12559574 | Use of succinate as biomarker in diagnosis and treatment of cancers | 🖼🧊📄§ | 2026-02-24 | 2040-10-16 | 0 | 31 |
| 12559723 | Platform for generating safe cell therapeutics | 🖼🧊📄§ | 2026-02-24 | 2042-12-15 | 0 | 31 |
| 12558436 | Composition and method for inhibiting tau protein accumulation, aggregation, and tangle formation | 🖼🧊📄§ | 2026-02-24 | 2040-09-15 | 0 | 31 |
| 12559718 | Diagnostic methods for t cell therapy | 🖼🧊📄§ | 2026-02-24 | 2043-08-24 | 0 | 31 |
| 12558316 | Methods and compositions for the treatment of epidermolysis bullosa | 🖼🧊📄§ | 2026-02-24 | 2037-09-22 | 0 | 31 |
| 12558309 | Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue | 🖼🧊📄§ | 2026-02-24 | 2043-09-15 | 0 | 31 |
| 12559572 | Compositions and methods for treating IgE-mediated disorders | 🖼🧊📄§ | 2026-02-24 | 2042-12-22 | 0 | 31 |
| 12558373 | Method for converting atrial fibrillation to sinus rhythm with low-risk, low-cost protocol, and preventing recurrence of atrial fibrillation | 🖼🧊📄§ | 2026-02-24 | 2044-10-04 | 0 | 31 |
| 12559769 | Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells | 🖼🧊📄§ | 2026-02-24 | 2038-06-15 | 0 | 31 |
| 12558343 | Medical use of icaritin | 🖼🧊📄§ | 2026-02-24 | 2041-03-09 | 0 | 31 |
| 12558364 | Next generation remdesivir antivirals | 🖼🧊📄§ | 2026-02-24 | 2042-01-19 | 0 | 31 |
| 12559499 | Uses of compounds having anti-HSV-1 activity | 🖼🧊📄§ | 2026-02-24 | 2040-01-29 | 0 | 31 |
| 12558360 | Compound useful for the treatment of degenerative and inflammatory diseases | 🖼🧊📄§ | 2026-02-24 | 2044-06-13 | 0 | 31 |
| 12558392 | Herbal oral compositions having the properties for supporting and enhancing musculoskeletal health and method of manufacturing the same | 🖼🧊📄§ | 2026-02-24 | 2045-07-23 | 0 | 31 |
| 12559747 | Retinitis pigmentosa treatment | 🖼🧊📄§ | 2026-02-24 | 2040-05-25 | 0 | 31 |
| 12559534 | Modified IL-2 proteins, peg conjugates, and uses thereof | 🖼🧊📄§ | 2026-02-24 | 2040-06-18 | 0 | 31 |
| 12558428 | Heterobifunctional compounds and their use in treating disease | 🖼🧊📄§ | 2026-02-24 | 2045-03-07 | 0 | 31 |